본문 바로가기
KERD
논문KCI 등재

Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

초록

Brain diseases and disorders such as Alzheimer disease, Parkinson disease, depression, schizophrenia, autism, and addiction lead to reduced quality of daily life through abnormal thoughts, perceptions, emotional states, and behavior. While the underlying mechanisms remain poorly understood, human and animal studies have supported a role of neuroinflammation in the etiology of these diseases. In the central nervous system, an increased inflammatory response is capable of activating microglial cells, leading to the release of pro-inflammatory cytokines including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α. In turn, the pro-inflammatory cytokines aggravate and propagate neuroinflammation, degenerating healthy neurons and impairing brain functions. Therefore, activated microglia may play a key role in neuroinflammatory processes contributing to the pathogenesis of psychiatric disorders and neurodegeneration.

Abstract

Brain diseases and disorders such as Alzheimer disease, Parkinson disease, depression, schizophrenia, autism, and addiction lead to reduced quality of daily life through abnormal thoughts, perceptions, emotional states, and behavior. While the underlying mechanisms remain poorly understood, human and animal studies have supported a role of neuroinflammation in the etiology of these diseases. In the central nervous system, an increased inflammatory response is capable of activating microglial cells, leading to the release of pro-inflammatory cytokines including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α. In turn, the pro-inflammatory cytokines aggravate and propagate neuroinflammation, degenerating healthy neurons and impairing brain functions. Therefore, activated microglia may play a key role in neuroinflammatory processes contributing to the pathogenesis of psychiatric disorders and neurodegeneration.

참고문헌 (54)

  1. Onore C, "The role of immune dysfunction in the pathophysiology of autism", Brain Behav Immun, 26, pp.383~392 (2012)
  2. Theoharides TC, "Focal brain inflammation and autism", J Neuroinflammation, 10, pp.46~ (2013)
  3. Theoharides TC, "Neuro-inflammation, blood-brain barrier, seizures and autism", J Neuroinflammation, 8, pp.168~ (2011)
  4. Najjar S, "Neuroinflammation and psychiatric illness", J Neuroinflammation, 10, pp.43~ (2013)
  5. Stertz L, "Is bipolar disorder an inflammatory condition? The relevance of microglial activation", Curr Opin Psychiatry, 26, pp.19~26 (2013)
  6. Reus GZ, "The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders", Neuroscience, 300, pp.141~154 (2015)
  7. Zhao Q, "Maternal sleep deprivation inhibits hippocampal neurogenesis associated with inflammatory response in young offspring rats", Neurobiol Dis, 68, pp.57~65 (2014)
  8. World alzheimer report 2015: the global impact of dementia. An analysis of prevalence, incid ence, cost and trends, "Prince M", Alzheimer’s Disease International, ~ (2015)
  9. Murphy MP, "Alzheimer’s disease and the β-amyloid peptide", J Alzheimers Dis, 19, pp.311~ (2010)
  10. Heneka MT, "Innate immune activation in neurodegenerative disease", Nat Rev Immunol, 14, pp.463~477 (2014)
  11. Norden DM, "Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease", Neuropharmacology, 96(Pt A), pp.29~41 (2015)
  12. Jack CR Jr, "Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade", Lancet Neurol, 9, pp.119~128 (2010)
  13. Sperling RA, "Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.280~292 (2011)
  14. Wirth M, "Alzheimer’s disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals", J Neurosci, 33, pp.5553~5563 (2013)
  15. Steiner N, "Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264.7 macrophages and C8-B4 microglia", Neurochem Int, 95, pp.46~54 (2015)
  16. Fahn S, "Description of Parkinson’s disease as a clinical syndrome", Ann N Y Acad Sci, 991, pp.1~14 (2003)
  17. Waak J, "Regulation of astrocyte inflammatory responses by the Parkinson’s disease-associated gene DJ-1", FASEB J, 23, pp.2478~2489 (2009)
  18. Wang Q, "Neuroinflammation in Parkinson’s disease and its potential as therapeutic target", Transl Neurodegener, 4, pp.19~ (2015)
  19. Wirdefeldt K, "Epidemiology and etiology of Parkinson’s disease: a review of the evidence", Eur J Epidemiol, 26(Suppl 1), pp.S1~S58 (2011)
  20. Hirsch EC, "Neuroinflammation in Parkinson’s disease", Parkinsonism Relat Disord, 18(Suppl 1), pp.S210~S212 (2012)
  21. Cagnin A, "In vivo evidence for microglial activation in neurodegenerative dementia", Acta Neurol Scand Suppl, 185, pp.107~114 (2006)
  22. Ferrari CC, "Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra", Neurobiol Dis, 24, pp.183~193 (2006)
  23. "Depression. Fact Sheet No.369" (2016)[URL]
  24. Ceretta LB, "Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients", Acta Diabetol, 49(Suppl 1), pp.S227~S234 (2012)
  25. Howren MB, "Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis", Psychosom Med, 71, pp.171~186 (2009)
  26. Dowlati Y, "A meta-analysis of cytokines in major depression", Biol Psychiatry, 67, pp.446~457 (2010)
  27. Miller AH, "Inflammation and its discontents:the role of cytokines in the pathophysiology of major depression", Biol Psychiatry, 65, pp.732~741 (2009)
  28. Frick LR, "Microglial dysregulation in psychiatric disease", Clin Dev Immunol, 2013, pp.608654~ (2013)
  29. Tynan RJ, "Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes", Acta Neuropathol, 126, pp.75~91 (2013)
  30. Couch Y, "Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia", Brain Behav Immun, 29, pp.136~146 (2013)
  31. Frank MG, "Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses", Brain Behav Immun, 21, pp.47~59 (2007)
  32. Diz-Chaves Y, "Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice", J Neuroinflammation, 9, pp.71~ (2012)
  33. Ohgi Y, "Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration", Pharmacol Biochem Behav, 103, pp.853~859 (2013)
  34. Tynan RJ, "A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia", Brain Behav Immun, 26, pp.469~479 (2012)
  35. Serafini G, "The role glutamate excitotoxicity and neuroinflammation in depression and suicidal behavior: focus on microglia cells", Neuroimmunol Neuroinflamm, 2, pp.127~130 (2015)
  36. Theoharides TC, "Mast cell activation and autism", Biochim Biophys Acta, 1822, pp.34~41 (2012)
  37. Morgan JT, "Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism", Brain Res, 1456, pp.72~81 (2012)
  38. Tetreault NA, "Microglia in the cerebral cortex in autism", J Autism Dev Disord, 42, pp.2569~2584 (2012)
  39. Suzuki K, "Microglial activation in young adults with autism spectrum disorder", JAMA Psychiatry, 70, pp.49~58 (2013)
  40. 이강파, "The anti-inflammatory effect of Indonesian Areca catechu leaf extract in vitro and in vivo", Nutrition Research and Practice, 8(3), pp.267~271 (2014), 한국영양학회
  41. Le Belle JE, "Maternal inflammation contributes to brain overgrowth and autism-associated behaviors through altered redox signaling in stem and progenitor cells", Stem Cell Reports, 3, pp.725~734 (2014)
  42. Hornig M, "An infectionbased model of neurodevelopmental damage", Proc Natl Acad Sci U S A, 96, pp.12102~12107 (1999)
  43. Koob GF, "Neurocircuitry of addiction", Neuropsychopharmacology, 35, pp.217~238 (2010)
  44. Leshner AI, "Addiction is a brain disease, and it matters", Science, 278, pp.45~47 (1997)
  45. Rodrigues LC, "Neuroinflammation as a possible link between cannabinoids and addiction", Acta Neuropsychiatr, 26, pp.334~346 (2014)
  46. Sadasivan S, "Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice", PLoS One, 7, pp.e33693~ (2012)
  47. Nakajima A, "Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity", J Neurosci, 24, pp.2212~2225 (2004)
  48. Zhao YN, "Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure", Behav Brain Res, 236, pp.270~282 (2013)
  49. Wang J, "Effect of Methamphetamine on the microglial damage: role of potassium channel Kv1.3", PLoS One, 9, pp.e88642~ (2014)
  50. Meyer U, "Developmental neuroinflammation and schizophrenia", Progr Neuropsychopharmacol Biol Psychiatry, 42, pp.20~34 (2013)
  51. Monji A, "Cytokines and schizophrenia: microglia hypothesis of schizophrenia", Psychiatry Clin Neurosci, 63, pp.257~265 (2009)
  52. Muller N, "The role of inflammation in schizophrenia", Front Neurosci, 9, pp.372~ (2015)
  53. Erta M, "Interleukin-6, a major cytokine in the central nervous system", Int J Bio Sci, 8, pp.1254~1266 (2012)
  54. Guadagno J, "Microgliaderived TNFα induces apoptosis in neural precursor cells via transcriptional activation of the Bcl-2 family member Puma", Cell Death Dis, 4, pp.e538~ (2013)

관련 논문AI추천

이 간행물의 다른 논문 (24건)